beta-1,4-N-Acetylgalactosaminyltransferase (CgtA)-1U
Description
beta-1,4-N-Acetylgalactosaminyltransferase (CgtA) (GM2/GD2 synthase) is a key enzyme which catalyzes the conversion of GM3, GD3 and lactosylceramide (LacCer) to GM2, GD2 and asialo-GM2 (GA2), respectively. beta-1,4-N-Acetylgalactosaminyltransferase (CgtA) is a key enzyme to control the synthesis of brain-enriched complex gangliosides[1].–Applications-Neuroscience-Neuromodulation-Formula-N/A-Citation–References-[1]Furukawa K, et al. Beta1,4-N-acetylgalactosaminyltransferase–GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides. Biochim Biophys Acta. 2002 Dec 19;1573(3):356-62.-CASNumber-67338-98-1-MolecularWeight-N/A-Compound Purity–SMILES-[beta-1,4-N-Acetylgalactosaminyltransferase]-Research_Area-Neurological Disease-Solubility-10 mM in DMSO-Target-Others-Isoform–Pathway-Others-MCE Product type-Enzyme